CEREVEL THERAPEUTICS HOLDING (CERE) Stock Analyst Earnings Estimates
NASDAQ:CERE - Nasdaq - US15678U1280 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 593.29% | N/A 162.99% | N/A 80.54% | N/A 71.26% | N/A 39.33% | ||||||
| EBITDA YoY % growth | N/A | -148.72M | -217.4M -46.18% | -362.95M -66.95% | -441.638M -21.68% | N/A -6.45% | N/A -9.79% | N/A -7.55% | N/A 30.69% | N/A 107.10% | N/A 1,081.34% | N/A 70.72% | N/A | |
| EBIT YoY % growth | -149.12M | -220.1M -47.60% | -367.85M -67.13% | -447.265M -21.59% | N/A -15.30% | N/A -6.79% | N/A -19.18% | N/A 44.04% | N/A 101.38% | N/A 9,190.53% | N/A 183.88% | N/A 53.40% | ||
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -1.65 68.75% | -2.33 -41.21% | -2.67 -14.59% | N/A 3.92% | N/A -11.33% | N/A -6.43% | N/A 28.02% | N/A 78.21% | N/A 483.96% | N/A 207.34% | N/A 54.08% |
All data in USD
| Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.72 -14.95% | -0.59 3.85% | -0.67 11.42% | -0.73 -0.60% | -0.74 -2.82% | -0.78 -32.17% | -0.80 -18.18% |
| Revenue Q2Q % growth | |||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -147.9M -52.73% | -137.598M -23.62% | -138.414M 0.82% | -127.5M 10.62% | -130.56M 11.72% | -136.68M 0.67% | -139.74M -0.96% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | -0.73 -8.96% | -0.62 | -0.11 | -17.05% |
| Q4 2023 Q2Q % growth | -0.76 -28.81% | -0.61 | -0.15 | -25.25% |
| Q3 2023 Q2Q % growth | -0.61 7.58% | -0.64 | 0.03 | 5.41% |
| Q2 2023 Q2Q % growth | -0.63 -1.61% | -0.66 | 0.03 | 4.77% |
| Q1 2023 Q2Q % growth | -0.67 -45.65% | -0.69 | 0.02 | 2.59% |
| Q4 2022 Q2Q % growth | -0.59 -47.50% | -0.65 | 0.06 | 9.76% |
| Q3 2022 Q2Q % growth | -0.66 -53.49% | -0.63 | -0.03 | -4.98% |
| Q2 2022 Q2Q % growth | -0.62 -47.62% | -0.49 | -0.13 | -27.78% |
| Q1 2022 Q2Q % growth | -0.46 -15.00% | -0.43 | -0.03 | -6.11% |
| Q4 2021 Q2Q % growth | -0.40 -48.15% | -0.41 | 0.01 | 3.57% |
| Q3 2021 Q2Q % growth | -0.43 | -0.40 | -0.03 | -6.28% |
| Q2 2021 Q2Q % growth | -0.42 | -0.40 | -0.02 | -4.91% |
| Q1 2021 Q2Q % growth | -0.40 | -0.42 | 0.02 | 5.12% |
| Q4 2020 Q2Q % growth | -0.27 | -0.46 | 0.19 | 41.18% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -2.99% | 0% | -0.91% |
| Revenue | N/A | N/A | N/A | N/A |